This inventor holds 1 USPTO granted patent. Top assignee: Kyungpook National University Industry-Academic Cooperation Foundation. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Innovator Hai Yan Hong and His Contribution to Atherosclerosis Research
Introduction
Hai Yan Hong, an accomplished inventor based in Daegu, South Korea, has made significant advancements in the field of medical science with his innovative research. He holds one patent that plays a crucial role in diagnosing, preventing, and treating atherosclerosis, a condition that poses serious health risks worldwide. His work is not only a testament to his expertise but also to the collaborative efforts in the biomedical research community.
Latest Patents
Hong's notable patent is focused on a peptide specifically designed for diagnosing, preventing, and treating atherosclerosis. The patent details the amino acid sequences as set forth in SEQ ID NO: 1 or SEQ ID NO: 2. This peptide effectively targets atherosclerotic plaques and binds to IL-4R, showcasing antagonistic effects on IL-4-mediated signaling that contributes to cellular inflammatory responses and survival reactions. The applications of this invention extend to the diagnosis and treatment of IL-4-induced inflammatory reactions, primarily linked to atherosclerosis, offering new avenues for prevention and treatment.
Career Highlights
Hai Yan Hong's career is marked by his dedication to research and innovation in the field of medical science. He currently works with the Kyungpook National University Industry-Academic Cooperation Foundation, where he continues to advance his research on cardiovascular diseases and inflammation.
Collaborations
Throughout his career, Hong has collaborated with esteemed colleagues, including Byung Heon Lee and In San Kim. Together, they contribute to a rich environment of research and innovation, driving progress in the understanding and treatment of complex health challenges like atherosclerosis.
Conclusion
In summary, Hai Yan Hong is a distinguished inventor whose groundbreaking work on peptides for atherosclerosis has potential implications for diagnosis and treatment. His patent reflects his commitment to addressing serious health issues through effective scientific innovation. With ongoing collaborations and research efforts, Hong continues to push the boundaries of medical science, contributing to the fight against cardiovascular diseases.